WORKSHOP B | 13.30 – 17.30

Parallel Trade – Management Strategies Workshop Leader:

Janice Haigh, Practice Leader, Market Access, Quintiles

www.parallel-trade.com Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711

ACADEMIC & GROUP DISCOUNTS AVAILABLE

PLUS TWO INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPSWednesday 8th February 2017, Holiday Inn Kensington Forum, London, UK

REGISTER BY 31ST OCTOBER AND SAVE £400REGISTER BY 30TH NOVEMBER AND SAVE £200REGISTER BY 16TH DECEMBER AND SAVE £100

@SMIPHARM

With Brexit and the new EU Falsifi ed Medicine Directive, what does the future hold for parallel trade? This event will discuss short term versus long term concerns of pharma manufacturers, regulators, as well as parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges. Discussion topics include:

• Parallel Trade 101 – Which factors determine the fl ow of pharmaceutical products in Europe?

• The European Commission’s Falsifi ed Medicines Directive – recent updates• Panel Debate – In the spotlight: Shortages• Parallel traders panel – challenges and opportunities• Beyond pharmaceutical products – parallel imports of medical devices• Panel Debate – In the spotlight: Technology and new trends• Regional and country focus – Scandinavia, UK and Eurasia

SMi Presents 11th Annual Conference & Exhibition on...

Parallel Trade The opportunities and challenges ahead – beyond FMD and Brexit

CONFERENCE: 6TH - 7TH

WORKSHOPS: 8TH

FEB 2017HOLIDAY INN KENSINGTON FORUM, LONDON, UK

CHAIRMAN: Eric Noehrenberg, Director, Regional Market Access Lead,

Latin America, Shire International GmbH

KEY SPEAKERS INCLUDE:• Heinz Kobelt, Director European Affairs, European Association of

Euro-Pharmaceutical Companies• Dr. Rick Greville, Director Wales and Director Distribution & Supply,

The Association of the British Pharmaceutical Industry• Tomasz Dzitko, President, Delfarma• Dr. Shabnam Hanassab, Senior Consultant, IMS Health• Dermot Glynn, Senior Advisor, Europe Economics• Katarzyna Kolasa, Science PhD, Warsaw Medical University• Mike Isles, Executive Director, European Alliance for Access to

Safe Medicines• Dr. Andrew Stainthorpe, Director Market Access and Managed

Entry, Research Health• Karoline Zwierzynska, Associate, Arnold & Porter (UK) LLP• Flemming Wagner, CEO, Abacus Medicine• Maarten Kamphuis, Business Development Director, Fisher Farma• Vladimir Zah, Health Economics Consultant, ISPOR

WORKSHOP A | 8.30 – 12.30

Understanding IP and competition law issues in parallel trade Workshop Leaders:

Kathy Osgerby, Associate, Arnold & Porter (UK) LLPKaroline Zwierzynska, Associate, Arnold & Porter (UK) LLP

MARKETING OPPORTUNITIESWant to know how you can get

involved? Interested in promoting your services to this market?

Contact – Anna Serazetdinova SMi Marketing on

+44 (0) 20 7827 6180 or email: aserazetdinova@smi-online.co.uk

Parallel Trade Day One | Monday 6th February 2017

8.30 Registration & Coffee

9.00 Chairman’s Opening Remarks Eric Noehrenberg, Director, Regional Market Access Lead,

Latin America, Shire International GmbH

OPENING ADDRESS9.10 Parallel Trade 101 – Which factors determine the fl ow of

pharmaceutical products in Europe? • Parallel exports and parallel imports – defi ning the terms • Beyond price differences and legal guidelines –

currency fl uctuations and much more • Parallel trade in the EU – key facts including value, key

import and source markets as well as key players • Impact on patients – shortages and quality • Current trends with parallel trade in pharmaceuticals in Europe Eric Noehrenberg, Director, Regional Market Access Lead,

Latin America, Shire International GmbH

9.50 The European Commission’s Falsifi ed Medicines Directive – recent updates

• Exploring the legal framework of the Falsifi ed Medicines Directive

• What progress has been made since February 2016? • Implementation of the Falsifi ed Medicines Directive - the

new rules on medicine verifi cation • All what you need to know about “product information

templates” • What are the regulatory requirements for nationally

authorised products? Dr Rick Greville, Director Wales and Director Distribution &

Supply, The Association of the British Pharmaceutical Industry

10.30 Morning Coffee

11.00 Initiatives of Parallel Distributors in the context of Falsifi ed Medicines Directive

• Good Parallel Distribution Guidelines • Early Warning Anti-CF Platform • Joint Audits Initiative • European Medicines Verifi cation Organization Tomasz Dzitko, President, Delfarma

11.40 European Medicines Verifi cation Organization – an update from Brussels

• Explaining the complexity behind the planning and design of a pan-European medicine verifi cation system

• Implementing national verifi cation systems that function at an equal level of effi cacy, are interoperable and cost effective

• The role of the European Hub and national data repositories

• EMVO and interactions with various supply chain stakeholders

Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies

12.10 Networking Lunch

PANEL DEBATE1.30 In the spotlight: Shortages • Shortages explained – manufacturing and

trade related shortages • The implications of parallel trade for low-price

countries • When Governments need to intervene

– Bulgaria’s case – oncology drugs • Examining an increased tendency to yield new

medicines’ availability in low income countries • Overcoming the challenges – on the road to a more

transparent and regulated distribution cycle • Will new potential trade barriers eliminate the shortages

problem? • Impact of possible import of products from outside the

EU into the EU Heinz Kobelt, Director European Affairs, European

Association of Euro-Pharmaceutical Companies Tomasz Dzitko, President, Delfarma

2.10 Which categories of pharmaceutical products offer highest margins for traders? What is a good profi t margin?

• Regional outlook – product range vs. product value for parallel trade in Europe

• The increasingly diversifi ed product portfolio for parallel distribution – challenges and opportunities

• Which categories of products are favoured by parallel distributors?

Vladimir Zah, Health Economics Consultant, ISPOR

2.50 Northern Europe – opportunities and challenges • An overview of latest developments in parallel trade in

Northern Europe (including Scandinavia) • Parallel trade – what does the future hold? • The benefi ts of parallel trade for the European society • Future threats to parallel trade Flemming Wagner, CEO, Abacus Medicine

3.30 Afternoon Tea

4.00 Region focus: Eurasia • Exploring regulatory aspects in Eurasia • Focus on Russia – reviewing the status after the recent

legalisation of parallel trade • Azerbaijan as a regional hub Alexey Savin, Principal Russia and CIS, IMS Health

4.40 Legal 101 - IP, competition and regulatory law • The impact of IP on parallel trade of pharmaceuticals • The competition restrictions on dual pricing, quota and

DTP models • How does the regulatory system deal with parallel

trade? Kathy Osgerby, Associate, Arnold & Porter (UK) LLP Karoline Zwierzynska, Associate, Arnold & Porter (UK) LLP

5.20 Chairman’s Closing Remarks and Close of Day One

REGIONAL FOCUS – FROM GERMANY TO EURASIA

PHARMACEUTICAL ANTI-COUNTERFEITING – COMBATING THE DANGER FROM FAKE DRUGS

LEGAL VIEW – INTELLECTUAL PROPERTY, COMPETITION AND REGULATORY CHALLENGES

Offi cial Publications

Register online at www.parallel-trade.com Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711

Offi cial Media Partners

HOT TOPIC – PANEL DEBATE

SPONSORSHIP AND EXHIBITION OPPORTUNITIESSMi offer sponsorship, exhibition, advertising and branding

packages, uniquely tailored to complement your company’s marketing strategy. Prime networking opportunities exist

to entertain, enhance and expand your client base within the context of an independent discussion specifi c to your industry. Should you wish to join the increasing number of companies benefi ting from sponsoring our conferences

please call: Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk

Parallel TradeDay Two | Tuesday 7th February 2017

Parallel Trade Day One | Monday 6th February 2017

8.30 Registration & Coffee

9.00 Chairman’s Opening Remarks Eric Noehrenberg, Director, Regional Market Access Lead,

Latin America, Shire International GmbH

OPENING PANEL DEBATE9.10 PANEL DEBATE: The big question – what will Brexit mean for

parallel trade to and from the UK? • Will a post-Brexit UK need a new trade deal with the

European Union? The impact of tariffs under a new trade deal

• How can wholesalers tackle the uncertainty until trading arrangements are fi nalised?

• How are the new circumstances affecting medicine supplies in the UK and the rest of Europe? The impact of currency fl uctuations and a weaker pound

• Short term concerns versus long term concerns • What can the UK learn from Switzerland and Norway? Dr Andrew Stainthorpe, Director Market Access and

Managed Entry, Research Health

9.50 European parallel trade – past, present and future • Key trends and dynamics in distribution and dispensing • Outlook and key factors likely to infl uence the market

going forward Dr. Shabnam Hanassab, Senior Consultant, IMS Health

10.30 Morning Coffee

11.00 The case against parallel trade in the EU – will the UK end parallel trade

• Patented pharmaceuticals are not like widgets • Parallel trade is wasteful and does no good • Parallel trade prevents poor people from being treated

with the best medicines Dermot Glynn, Senior Advisor, Europe Economics

11.40 Parallel traders panel – challenges and opportunities • How traders can work together to improve supply chain

safety – unleashing the potential of collaboration • Strategies for overcoming the threat to patients posed by

counterfeit drugs - the role of traders in ensuring product quality and safety

• An overview of initiatives in the context of Falsifi ed Medicines Directive

Flemming Wagner, CEO, Abacus Medicine Maarten Kamphuis, Business Development Director,

Fisher Farma

12.20 Networking Lunch

1.30 Beyond pharmaceutical products – parallel imports of

medical devices

• Benchmarking market conditions for medical devices with

pharmaceutical products

• Recent regulations and guidelines for parallel importers of

medical devices

• What pharmaceutical companies can learn from medical

devices manufacturers?

Katarzyna Kolasa, Science PhD, Warsaw Medical University

2.10 Fighting fakes by raising public awareness – how to

change consumer behaviours

• An overview of statistical trends and the rising threat

• What are the most effi cient ways to address the safety

and legitimacy of websites selling medicines

• The power of educational websites – convincing

results that raising consumer awareness can change

behaviours

• What organisations actively collaborate to enhance

patient safety and how can you get involved

Mike Isles, Executive Director, European Alliance for

Access to Safe Medicines

2.50 Managed entry schemes, HTA and parallel trade

• Managed entry arrangements are becoming the norm for

high cost drugs

• How schemes are tailored to each market - including

national, regional and local arrangements

• Exploring available mechanisms to address risks

Dr Andrew Stainthorpe, Director Market Access and

Managed Entry, Research Health

3.30 Afternoon Tea

4.00 Recap of the 2017 Meeting – Ask the Panel and Audience

Delegates will have the fi nal chance to ask speakers and

colleagues plus summing up what they’ve learnt over the

2-day meeting. It’ll be a recap for objectives set on Day 1

and sharing of key takeaways.

Eric Noehrenberg, Director, Regional Market Access Lead,

Latin America, Shire International GmbH

4.40 Chairman’s Closing Remarks and Close of Day Two

HOT TOPIC – PANEL DEBATE

NEW TRENDS AND THEIR IMPACT ON PARALLEL TRADE

Supported byOffi cial Publications

Register online at www.parallel-trade.com Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711

THE FUTURE OF PARALLEL TRADE

Offi cial Media Partners

Understanding IP and competition law issues in parallel trade

Workshop Leader: Kathy Osgerby, Associate, Arnold & Porter (UK) LLP

Karoline Zwierzynska, Associate, Arnold & Porter (UK) LLP

HALF-DAY POST-CONFERENCE WORKSHOP AWednesday 8th February 2017

08.30 – 12.30Holiday Inn Kensington Forum, London, UK

Overview of Workshop:

This half day workshop will explore in depth how IP and competition law can affect parallel trade. Through interactive case studies, it will provide insight into the use of trade mark rights to prevent the sale of repackaged parallel imports, and the potential competition law issues raised by strategies to manage parallel trade.

Programme:

8.30 Workshop Registration & Morning Coffee

9.00 Workshop Leader introduction

9.10 Case study 1: Responding to a repackaging notifi cation

• Legal principles - trade mark exhaustion and the BMS conditions for repackaging

• BMS conditions - when and how can goods be repackaged?

• Consent to sale of goods in the EEA - what about related and group companies?

• Other notifi cations - regulatory and specifi c mechanism

• Will things change post-Brexit?

10.30 Morning Coffee & Networking Break

11.00 Case study 2: Competition law and management strategies

• Legal principles - Articles 101/102 TFEU and case law

• Quota systems and potential risks • Agency (direct to pharmacy/hospital) systems

and potential risks • Other competition risks and red fl ags

12.00 Discussion – Q&A

12.30 Closing remarks from Workshop leader and end of morning workshop

About the Workshop Leaders:

Kathy Osgerby is an Associate in the IP team at Arnold & Porter in London. She advises clients on contentious intellectual property matters and has extensive experience in the life sciences industry. She

advises clients on the full range of IP issues including trade mark enforcement, parallel trade and exhaustion of rights. Kathy has a degree in Molecular Biology and Biochemistry, studied intellectual property law at a postgraduate level, and is a qualifi ed solicitor advocate.

Karoline Zwierzynska is an Associate in thecompetition team at Arnold & Porter in London. She has extensive experience of advising clients in the pharmaceutical sector and advises on a wide range

of transactional and conduct-related UK and EU competition law issues, including EU and multi-jurisdictional merger clearances and abuse of dominance investigations, including by dawn raid, commercial agreements and regulatory matters. In addition, she has also advised non-governmental organisations and has particular experience delivering training on UK and EU competition law compliance. Prior to joining Arnold & Porter, Karoline worked in the fi eld of academic research and has co-authored several peer-reviewed publications in developmental and clinical psychology. She holds a psychology degree from the University of Warwick.

About the Organisation:

Arnold & Porter LLP is an Am Law 100 fi rm focusing on the intersection of business, law, and public policy. The fi rm is known for:• Excellence of work in complex and challenging matters• More than 75 attorneys who have held senior positions in US

and European governments and international organizations• Ability to team effectively with clients and other outside

counsel and advisers• Broad reach across geographic, commercial, cultural, and

ideological borders• Interdisciplinary teams• Ability to assist clients with their international business needs• Chosen as outside counsel by 10 of the FORTUNE 25

companies, 43 of the FORTUNE 100 companies, and more than 2,500 other companies of all sizes

Supported by

Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711

Understanding IP and competition law issues in parallel trade

Workshop Leader: Kathy Osgerby, Associate, Arnold & Porter (UK) LLP

Karoline Zwierzynska, Associate, Arnold & Porter (UK) LLP

HALF-DAY POST-CONFERENCE WORKSHOP AWednesday 8th February 2017

08.30 – 12.30Holiday Inn Kensington Forum, London, UK

Overview of Workshop:

This half day workshop will explore in depth how IP and competition law can affect parallel trade. Through interactive case studies, it will provide insight into the use of trade mark rights to prevent the sale of repackaged parallel imports, and the potential competition law issues raised by strategies to manage parallel trade.

Programme:

8.30 Workshop Registration & Morning Coffee

9.00 Workshop Leader introduction

9.10 Case study 1: Responding to a repackaging notifi cation

• Legal principles - trade mark exhaustion and the BMS conditions for repackaging

• BMS conditions - when and how can goods be repackaged?

• Consent to sale of goods in the EEA - what about related and group companies?

• Other notifi cations - regulatory and specifi c mechanism

• Will things change post-Brexit?

10.30 Morning Coffee & Networking Break

11.00 Case study 2: Competition law and management strategies

• Legal principles - Articles 101/102 TFEU and case law

• Quota systems and potential risks • Agency (direct to pharmacy/hospital) systems

and potential risks • Other competition risks and red fl ags

12.00 Discussion – Q&A

12.30 Closing remarks from Workshop leader and end of morning workshop

About the Workshop Leaders:

Kathy Osgerby is an Associate in the IP team at Arnold & Porter in London. She advises clients on contentious intellectual property matters and has extensive experience in the life sciences industry. She

advises clients on the full range of IP issues including trade mark enforcement, parallel trade and exhaustion of rights. Kathy has a degree in Molecular Biology and Biochemistry, studied intellectual property law at a postgraduate level, and is a qualifi ed solicitor advocate.

Karoline Zwierzynska is an Associate in thecompetition team at Arnold & Porter in London. She has extensive experience of advising clients in the pharmaceutical sector and advises on a wide range

of transactional and conduct-related UK and EU competition law issues, including EU and multi-jurisdictional merger clearances and abuse of dominance investigations, including by dawn raid, commercial agreements and regulatory matters. In addition, she has also advised non-governmental organisations and has particular experience delivering training on UK and EU competition law compliance. Prior to joining Arnold & Porter, Karoline worked in the fi eld of academic research and has co-authored several peer-reviewed publications in developmental and clinical psychology. She holds a psychology degree from the University of Warwick.

About the Organisation:

Arnold & Porter LLP is an Am Law 100 fi rm focusing on the intersection of business, law, and public policy. The fi rm is known for:• Excellence of work in complex and challenging matters• More than 75 attorneys who have held senior positions in US

and European governments and international organizations• Ability to team effectively with clients and other outside

counsel and advisers• Broad reach across geographic, commercial, cultural, and

ideological borders• Interdisciplinary teams• Ability to assist clients with their international business needs• Chosen as outside counsel by 10 of the FORTUNE 25

companies, 43 of the FORTUNE 100 companies, and more than 2,500 other companies of all sizes

Parallel Trade – Management Strategies

Workshop Leader: Janice Haigh, Practice Leader, Market Access, Quintiles

Overview of Workshop:With a volatile macro-economic and evolving regulatory environment, parallel trade activities have introduced new dynamics to pharmaceutical market in 2015. Pharmaceutical manufacturers now recognise it is a cross departmental effort to ensure business integrity. This workshop educate attendees on the following:

• Challenges of logistics and supply• Importance of accurate measurement and affi liate

partnerships in import and export markets• Revenue and profi t• Ensuring patient supply

Programme:

13.30 Workshop Registration and Coffee

14.00 Workshop leader introduction

14.15 Background to Parallel Trade (PT)

14.25 PT Management Options

15.00 An Overview of Supply Management

15.30 Afternoon Tea

16.00 Critical Success Factors

16.30 Review of Tactical Details

17.00 Discussion and Q&A

17.30 End of Workshop

About the Workshop Leader: Janice joined Quintiles Consulting in January 2012. Janice has 25 years pricing and market access strategy experience gained through a variety of consulting roles and in pharma.

She was with IMS/Cambridge Pharma for almost 10 years before joining Astellas Pharma Europe as senior director of pricing and market access in 2006.

About the Organisation:Quintiles (NYSE: Q) helps biopharma and other healthcare companies improve their probability of success by connecting insights from our deep scientifi c, therapeutic and analytics expertise with superior delivery for better outcomes. From advisory through operations, Quintiles is the world’s largest provider of product development and integrated healthcare services.

HALF-DAY POST-CONFERENCE WORKSHOP BWednesday 8th February 2017

13.30 – 17.30Holiday Inn Kensington Forum, London, UK

Please complete fully and clearly in capital letters. Please photocopy for additional delegates.

Title: Forename:

Surname:

Job Title:

Department/Division:

Company/Organisation:

Email:

Company VAT Number:

Address:

Town/City:

Post/Zip Code: Country:

Direct Tel: Direct Fax:

Mobile:

Switchboard:

Signature: Date:I agree to be bound by SMi’s Terms and Conditions of Booking.

ACCOUNTS DEPT

Title: Forename:

Surname:

Email:

Address (if different from above):

Town/City:

Post/Zip Code: Country:

Direct Tel: Direct Fax:

Payment: If payment is not made at the time of booking, then an invoice will be issued and must be paid immediately and prior to the start of the event. If payment has not been received then credit card details will be requested and payment taken before entry to the event. Bookings within 7 days of event require payment on booking. Access to the Document Portal will not be given until payment has been received.Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another delegate to take your place at any time prior to the start of the event. Two or more delegates may not ‘share’ a place at an event. Please make separate bookings for each delegate.Cancellation: If you wish to cancel your attendance at an event and you are unable to send a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing that cancellation is made in writing and received at least 28 days prior to the start of the event. Regretfully cancellation after this time cannot be accepted. We will however provide the conferences documentation via the Document Portal to any delegate who has paid but is unable to attend for any reason. Due to the interactive nature of the Briefi ngs we are not normally able to provide documentation in these circumstances. We cannot accept cancellations of orders placed for Documentation or the Document Portal as these are reproduced specifi cally to order. If we have to cancel the event for any reason, then we will make a full refund immediately, but disclaim any further liability.Alterations: It may become necessary for us to make alterations to the content, speakers, timing, venue or date of the event compared to the advertised programme.Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other products and services. Unless you tick here □ we may also share your data with third parties offering complementary products or services. If you have any queries or want to update any of the data that we hold then please contact our Database Manager databasemanager@smi-online.co.uk or visit our website www.smi-online.co.uk/updates quoting the URN as detailed above your address on the attached letter.

Payment must be made to SMi Group Ltd, and received before the event, by one of the following methods quoting reference P-195 and the delegate’s name. Bookings made within 7 days of the event require payment on booking, methods of payment:

□ UK BACS Sort Code 300009, Account 00936418□ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU Swift (BIC): LOYDGB21013, Account 00936418 IBAN GB48 LOYD 3000 0900 9364 18□ Cheque We can only accept Sterling cheques drawn on a UK bank.□ Credit Card □ Visa □ MasterCard □ American Express All credit card payments will be subject to standard credit card charges.

Card No: □□□□ □□□□ □□□□ □□□□Valid From □□/□□ Expiry Date □□/□□CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card

Cardholder’s Name:

Signature: Date:I agree to be bound by SMi’s Terms and Conditions of Booking.

Card Billing Address (If different from above):

VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on Document portal and literature distribution for all UK customers and for those EU Customers not supplying a registration number for their own country here. ______________________________________________________________________________________

If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email events@smi-online.co.uk

□ Book by 31st October to receive £400 off the conference price□ Book by 30th November to receive £200 off the conference price□ Book by 16th December to receive £100 off the conference price

EARLY BIRD DISCOUNT

I would like to attend: (Please tick as appropriate) Fee Total

□ Conference & 2 Workshops £2697.00 + VAT £3236.40□ Conference & 1 Workshop A □ B □ £2098.00 + VAT £2517.60□ Conference only £1499.00 + VAT £1798.80□ 2 Workshops £1198.00 + VAT £1437.60□ 1 Workshop only A □ B □ £599.00 + VAT £718.80

PROMOTIONAL LITERATURE DISTRIBUTION □ Distribution of your company’s promotional

literature to all conference attendees £999.00 + VAT £1198.80

The conference fee includes refreshments, lunch, conference papers, and access to the Document Portal. Presentations that are available for download will be subject to distribution rights by speakers. Please note that some presentations may not be available for download. Access information for the document portal will be sent to the e-mail address provided during registration. Details are sent within 24 hours post conference.

□ Please contact me to book my hotelAlternatively call us on +44 (0) 870 9090 711, email: events@smi-online.co.uk or fax +44 (0) 870 9090 712

I cannot attend but would like to purchase access to the following Document Portal/paper copy documentation Price Total□ Access to the conference documentation

on the Document Portal £499.00 + VAT £598.80□ The Conference Presentations – paper copy £499.00 - £499.00

(or only £300 if ordered with the Document Portal)

Unique Reference Number

Our Reference LVP-195

DELEGATE DETAILS

Terms and Conditions of Booking

PAYMENT

VAT

CONFERENCE PRICES

DOCUMENTATION

VENUE Holiday Inn Kensington Forum, 97 Cromwell Rd, London SW7 4DN, UK

PARALLEL TRADEConference: Monday 6th & Tuesday 7th February 2017, Holiday Inn Kensington Forum, London, UK

Workshop: Wednesday 8th February 2017, London, UK

4 WAYS TO REGISTERwww.parallel-trade.com

FAX your booking form to +44 (0) 870 9090 712PHONE on +44 (0) 870 9090 711

POST your booking form to: Events Team, SMi Group Ltd, Ground & First Floor, 1 Westminster Bridge Road London, SE1 7XW, UK